Wedbush Thinks Pacira Pharma Is Worth $106 On Exparel Sales

By: via Benzinga
In a report issued Wednesday, Wedbush analysts Liana Moussatos and Kelechi Chikere looked into Pacira Pharmaceuticals Inc (NASDAQ: PCRX) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.